Overview
Cohort Study to Determine the Long-Term Safety and Efficacy of Biogeneric Epoetin Treatment for Renal Anemia
Status:
Unknown status
Unknown status
Trial end date:
2011-04-01
2011-04-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to establish the long-term safety and efficacy of Biogeneric Epoetin, the attainability of therapeutic target for anaemia management, and the impact of Epoetin treatment on long-term health outcome and its cost effectiveness.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Ministry of Health, MalaysiaTreatments:
Epoetin Alfa
Criteria
Inclusion Criteria:- Patient who has Chronic Kidney Disease with anaemia for which Epoetin treatment is
indicated.
- Patient without known hypersensitivity to the mammalian cell-derived product or human
albumin products.